Recovery & Tissue Repair research peptides

The short version

This is a reference desk, not a store. Despite the name — which is a holdover and is addressed on the about page — this site sells nothing. It collects what the published research literature actually reports about two peptides that appear repeatedly in discussions about recovery and tissue repair: GHK-Cu and BPC-157.

A peptide is a short chain of amino acids, the same building blocks that make up proteins, only far smaller. These two have attracted research interest because each appears to interact with some part of the body's repair and matrix-maintenance machinery. GHK-Cu does it from the collagen side — it is a three-amino-acid sequence embedded in type I collagen itself, complexed to copper, and it signals cells to rebuild their scaffolding. BPC-157 approaches from the tissue-protection angle: a fifteen-amino-acid synthetic peptide drawn from a stomach protein, with a decades-long animal record tied mostly to the growth of new blood vessels into injured tissue.

This desk does one job: it tells you, in plain language and with citations, what each peptide was actually tested on, in which species, and how far that evidence reaches. Neither is an approved medicine. We give no medical advice and list no human doses.

What this desk covers

The two peptides here share a theme — collagen, extracellular matrix, and tissue-matrix research — but approach it from different angles.

• GHK-Cu is the lead. It is a copper-binding tripeptide whose documented effects center on fibroblast signaling and matrix construction: stimulating collagen, elastin and glycosaminoglycan synthesis, regulating matrix metalloproteinases, and enabling the cross-linking enzymes that knit the scaffold together ^[6][7]. It has the strongest human evidence of the two, though most of it is topical. It also has a documented gene-expression reach that is unusually broad for a molecule this small ^[2].
• BPC-157 approaches repair through cytoprotection and angiogenesis. Its best-characterized mechanism is up-regulation of the VEGFR2 vessel-growth receptor, which accelerates blood-supply restoration to damaged tissue ^[11]. Its animal record spans tendon, gut, muscle and nerve; its human file as of 2025 consists of only three small pilot reports ^[9].

Read them individually, or compare these peptides on a single page.

Collagen, ECM and the tissue-matrix frame

The extracellular matrix — the collagen-and-glycoprotein scaffolding that sits between cells — is central to how tissue forms, holds together, and heals after injury. Fibroblasts secrete the raw materials; cross-linking enzymes bolt it together; matrix metalloproteinases trim and remodel it; and a library of growth factors, peptides and cytokines regulate the entire process.

GHK-Cu sits squarely inside this biology. The GHK tripeptide sequence actually occurs within the alpha-2(I) chain of type I collagen, which is the predominant structural collagen in skin and tendon. When collagen is cleaved during normal turnover, the released GHK-Cu complex appears to act as a local signal for fibroblast activation and new matrix deposition — a biological timer built into the scaffold itself ^[4][6]. BPC-157 enters from a different direction: it supports the vascular supply that matrix-making cells depend on, and its gastroprotective origin points to a possible gut-mucosal matrix role as well ^[12].

Neither peptide is a collagen supplement in the usual sense. They are signaling and regulatory molecules that interact with the biological machinery behind collagen production and tissue repair, and the research on them is conducted at that level: in cell cultures, in animal models, and only rarely in small human studies.

What are research peptides?

Proteins in the body — collagen in a tendon, an enzyme in the gut, a hormone in the bloodstream — are long amino-acid chains folded into precise shapes. A peptide is a much shorter chain of the same amino acids, sometimes only three or four links long. Because they are small and specific, peptides can act like keys that fit particular locks (receptors or enzymes) on cell surfaces, activating or modulating narrow biological processes.

A research peptide is one that has been synthesized and studied in the laboratory — in cell cultures, in animals, and occasionally in early human pilots — but has not been approved by a regulatory body as a medicine. Suppliers sell these compounds for laboratory research only, which means dosing, long-term safety and real-world effectiveness in people are typically unestablished. When this desk reports a number from a study, it reports it the way the study did: studied at X in rats or in a topical clinical trial of n=45 women. It is a description of what was researched, never a recommendation.